330 related articles for article (PubMed ID: 10467416)
1. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
2. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
[TBL] [Abstract][Full Text] [Related]
3. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
4. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
6. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
[TBL] [Abstract][Full Text] [Related]
7. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
Weinberg WC; Montano NE; Deng C
Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
11. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
12. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
[TBL] [Abstract][Full Text] [Related]
14. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
17. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
[TBL] [Abstract][Full Text] [Related]
18. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
[TBL] [Abstract][Full Text] [Related]
19. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
[TBL] [Abstract][Full Text] [Related]
20. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]